Furthermore, CB-1158 treatment was synergistic in combination with checkpoint blockade in multiple mouse models of cancer, resulting in increased tumour-infiltrating CD8+ T cells and NK cells, inflammatory cytokines, and expression of IFN-inducible genes [271]. Here, CD8A is linked to cancer.